"There is a clear association between the use of GLPs and increased risks of food retention during upper endoscopy," Mathur ...

Among 140 patients who underwent colonoscopy or a colonoscopy-plus-EGD, "inadequate bowel preparation" (stool retained in the bowel) was observed in 21.3% of those who were taking a GLP-1 medicine ...

With early phase 1 data now out in the wild, metabolic disease outfit Metsera is wasting no time locking down supplies of its ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

MangoRx aims to capitalize on growing demand for GLP-1 treatments to drive revenue growth and expand market share in the weight loss ...

Evan Seigerman, BMO senior analyst, joins 'Closing Bell Overtime' to talk today's Capitol Hill hearing with Novo Nordisk's ...

The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...

The quest for effective and safe weight loss solutions has long been a focus of medical research. In recent years, a novel ...

Read here for an analysis of LifeVantage's (LFVN) stock surge post GLP-1 trial, cautioning on pricing, retention, and ...

People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

Results of the human clinical trial will be shared with LifeVantage Consultants at Market Connect in Kansas City, October ...